Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati in Ecuador
Ecuador: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati was 76.0% in 2025. ▲ Rising
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati in Ecuador, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Ecuador is 76.0%, measured in 2025.
Compared with earlier readings it is down 11.6% on the previous year and down 6.2% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Ecuador peaked at 94.0% in 2012 and was at its lowest, 0.0%, in 2008.
That places Ecuador 128th out of 194 countries with data for 2025, putting it in the middle of the range.
The long-run direction has been consistently rising across the 18 years of available data.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 77.5% | 17.0% | 94.0% | 10 |
| 2020s | 75.0% | 62.0% | 86.0% | 6 |
Countries ranked near Ecuador
More health data for Ecuador
- Heat deaths vs projected death rates 1,324 (2090)
- Un projection of annual infant deaths 354 (2100)
- Deaths in armed conflicts by country 0 (2026)
- Deaths in armed conflicts by region 0 (2026)
- Age population, age 25, male, interpolated 157,554 (2025)
- Age population, age 25, female, interpolated 153,270 (2025)
- Age population, age 24, male, interpolated 157,639 (2025)
- Age population, age 24, female, interpolated 152,970 (2025)
- Age population, age 23, male, interpolated 157,678 (2025)
- Age population, age 23, female, interpolated 152,655 (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Ecuador?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Ecuador was 76.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati recorded in Ecuador?
- The highest recorded value was 94.0% in 2012.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati recorded in Ecuador?
- The lowest recorded value was 0.0% in 2008.
- How does Ecuador rank for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Ecuador ranks 128th out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati rising or falling in Ecuador?
- Over the last ten years it is down 6.2%. The long-run trend across the full record is rising.
- Where does this Ecuador data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).